anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Analyze Data

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 58,039
Current window 32,221-32,250
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all
18 30 60

Slide function

32,221-32,250 of 58,039

filter-aware
07
MainStreet Bancshares | Results Presentation Deck | 31 slidesMainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The chart combines a bar chart for QoQ Deposit Beta and a line chart for interest rates/costs.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
The chart uses a stacked bar format to distinguish between general non-interest income and swap fee income.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
10
The slide shows a downward trend in efficiency ratio (positive) and a fluctuating trend in equity/assets.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
The slide displays two line charts tracking financial performance over time.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
12
The slide highlights financial performance metrics for MainStreet Bancshares, Inc. with specific footnotes regarding non-GAAP measures and valuation divergence.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
13
The chart uses a combination of a bar chart for asset values and a line chart with callout nodes for historical events.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The slide highlights a 38% CAGR for DDA and notes that core deposits make up 71% of the total.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The table reconciles beginning net loans to ending net loans, adjusting for new loans, repayments, fees, ALLL, and PPP loans.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The CAGR is calculated for the period 2015-2021.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The chart displays the breakdown of Construction vs Non-Owner Occupied loans within the CRE portfolio.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Includes a table of credit quality ratios and non-performing assets, a bar chart of loss reserves, and two line charts showing NPAs/Assets and ALLL/Gross Loans.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide highlights the cost and structure of subordinated debt as a component of the holding company's capital stack.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Data is YTD as of 9/30/22.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
27
The table includes GAAP and Non-GAAP metrics, including core adjustments and balance sheet averages.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Action1 hit
28
The table includes both GAAP and Non-GAAP financial measures.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Action1 hit
17
Includes n/N counts and specific clinical trial footnotes regarding patient outcomes and data status.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
04
The slide presents preliminary financial data for the third quarter of 2022, including income statement components and key balance sheet items.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
06
The chart compares quarterly container volumes between 2021 and 2022.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
07
The chart shows a 15.1% decrease in Q3 2022 volume compared to Q3 2021.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
08
The chart compares quarterly container volumes between 2021 and 2022.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
09
Includes a footnote regarding 4Q21 volume benefit from a 53rd week.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
10
The chart shows quarterly operating income for 2021 and 2022, with Q3 2022 highlighted as a range.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
10
Study methodology involves 10-week treatment on high fat/fructose/CHO diet.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
11
Study design timeline included; statistical significance noted for treatment groups.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
12
Includes definitions for abbreviations and source citations.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
Data from preclinical study in HF-DIO mice.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
17
The slide highlights that DA-1726 efficacy is likely due to dual GLP1R/GCGR agonism.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Study uses male DIO-NASH mice with 30-week GAND feeding and 9-week treatment regimen.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
19
Includes study methodology timeline and statistical significance markers.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit